publicacions - Vall d`Hebron

PUBLICACIONS
1. Vicario M, González-Castro AM, Martínez C, Lobo B, Pigrau M, Guilarte M, de Torres I,
Mosquera JL, Fortea M, Sevillano-Aguilera C, Salvo-Romero E, Alonso C, Rodiño-Janeiro
BK, Söderholm JD, Azpiroz F, Santos J: Increased humoral immunity in the jejunum of
diarrhoea-predominant irritable bowel syndrome associated with clinical
manifestations. Gut 2015, 64:1379–88.
2. Bova M, Guilarte M, Sala-Cunill A, Borrelli P, Rizzelli GML, Zanichelli A: Treatment of
ACEI-related angioedema with icatibant: a case series. Intern Emerg Med 2015,
10:345–50.
3. Selva-O’Callaghan A, Trallero-Araguás E, Martínez MA, Labrador-Horrillo M, PinalFernández I, Grau-Junyent JM, Juárez C: Inflammatory myopathy: diagnosis and
clinical course, specific clinical scenarios and new complementary tools. Expert Rev
Clin Immunol 2015, 11:737–47
4. Selva-O’Callaghan A, Trallero-Araguás E, Labrador-Horrillo M: More on remission of
recalcitrant dermatomyositis treated with ruxolitinib. N Engl J Med 2015, 372:1273–
4.
5. Silveira MG, Selva-O’Callaghan A, Ramos-Terrades N, Arredondo-Agudelo K V,
Labrador-Horrillo M, Bravo-Masgoret C: Anti-MDA5 dermatomyositis and progressive
interstitial pneumonia. QJM 2016, 109:49–50.
6. Sala-Cunill A, Björkqvist J, Senter R, Guilarte M, Cardona V, Labrador M, Nickel KF,
Butler L, Luengo O, Kumar P, Labberton L, Long A, Di Gennaro A, Kenne E, Jämsä A,
Krieger T, Schlüter H, Fuchs T, Flohr S, Hassiepen U, Cumin F, McCrae K, Maas C,
Stavrou E, Renné T: Plasma contact system activation drives anaphylaxis in severe
mast cell–mediated allergic reactions. J Allergy Clin Immunol 2015, 135:1031-43.
7. Corominas M, Postigo I, Cardona V, Lleonart R, Romero-Pinel L, Martinez J: IgEmediated allergic reactions after the first administration of glatiramer acetate in
patients with multiple sclerosis. Int Arch Allergy Immunol 2014, 165:244–6.
8. Cardona V, Garriga T: [Allergic asthma.]. Med Clin (Barc) 2014, 144:216–22.
9. Luengo O, Cardona V: Component resolved diagnosis: when should it be used? Clin
Transl Allergy 2014, 4:28.
10. Nwaru BI, Hickstein L, Panesar SS, Muraro a, Werfel T, Cardona V, Dubois a EJ, Halken
S, Hoffmann-Sommergruber K, Poulsen LK, Roberts G, Van Ree R, Vlieg-Boerstra BJ,
Sheikh a: The epidemiology of food allergy in Europe: a systematic review and metaanalysis. Allergy 2014, 69:62–75.
11. Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, Santos AF,
Zolkipli ZQ, Bellou A, Beyer K, Bindslev-Jensen C, Cardona V, Clark AT, Demoly P,
Dubois AEJ, DunnGalvin A, Eigenmann P, Halken S, Harada L, Lack G, Jutel M,
Niggemann B, Ruëff F, Timmermans F, Vlieg-Boerstra BJ, Werfel T, Dhami S, Panesar S,
Akdis CA, Sheikh A: Anaphylaxis: guidelines from the European Academy of Allergy
and Clinical Immunology. Allergy 2014, 69:1026-45.
12. Dhami S, Panesar SS, Roberts G, Muraro A, Worm M, Bilò MB, Cardona V, Dubois AEJ,
DunnGalvin A, Eigenmann P, Fernandez-Rivas M, Halken S, Lack G, Niggemann B, Rueff
F, Santos AF, Vlieg-Boerstra B, Zolkipli ZQ, Sheikh A: Management of anaphylaxis: a
systematic review. Allergy 2014, 69:168–75.
13. Colobran R, Lois S, de la Cruz X, Pujol-Borrell R, Hernández-González M, Guilarte M:
Identification and characterization of a novel splice site mutation in the SERPING1
gene in a family with hereditary angioedema. Clin Immunol 2014, 150:143–8.
14. Colobran R, Pujol-Borrell R, Hernández-González M, Guilarte M: A novel splice site
mutation in the SERPING1 gene leads to haploinsufficiency by complete degradation
of the mutant allele mRNA in a case of familial hereditary angioedema. J Clin
Immunol 2014, 34:521–3.
15. De Silva D, Geromi M, Halken S, Host a, Panesar SS, Muraro a, Werfel T, HoffmannSommergruber K, Roberts G, Cardona V, Dubois a EJ, Poulsen LK, Van Ree R, VliegBoerstra B, Agache I, Grimshaw K, O’Mahony L, Venter C, Arshad SH, Sheikh a: Primary
prevention of food allergy in children and adults: systematic review. Allergy 2014,
69:581–9.
16. Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen
C, Cardona V, Dubois A, duToit G, Eigenmann P, Fernandez Rivas M, Halken S, Hickstein
L, Høst A, Knol E, Lack G, Marchisotto MJ, Niggemann B, Nwaru BI, Papadopoulos NG,
Poulsen LK, Santos AF, Skypala I, Schoepfer A, Van Ree R, Venter C, Worm M, VliegBoerstra B, Panesar S, de Silva D, et al.: EAACI Food Allergy and Anaphylaxis
Guidelines: diagnosis and management of food allergy. Allergy 2014, 69:1026-45.
17. De Silva D, Geromi M, Panesar SS, Muraro a, Werfel T, Hoffmann-Sommergruber K,
Roberts G, Cardona V, Dubois a EJ, Halken S, Host a, Poulsen LK, Van Ree R, VliegBoerstra BJ, Agache I, Sheikh a: Acute and long-term management of food allergy:
systematic review. Allergy 2014, 69:159–67.
18. Muraro a, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, Santos a F,
Zolkipli ZQ, Bellou a, Beyer K, Bindslev-Jensen C, Cardona V, Clark a T, Demoly P,
Dubois a EJ, DunnGalvin a, Eigenmann P, Halken S, Harada L, Lack G, Jutel M,
Niggemann B, Ruëff F, Timmermans F, Vlieg-Boerstra BJ, Werfel T, Dhami S, Panesar S,
Akdis C a, Sheikh a: Anaphylaxis: guidelines from the European Academy of Allergy
and Clinical Immunology. Allergy 2014, 69:1026–45.
19. Simons FER, Ardusso LR, Bilò M, Cardona V, Ebisawa M, El-Gamal YM, Lieberman P,
Lockey RF, Muraro A, Roberts G, Sanchez-Borges M, Sheikh A, Shek LP, Wallace D V,
Worm M: International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014,
7:9.
20. Worm M, Moneret-Vautrin A, Scherer K, Lang R, Fernandez-Rivas M, Cardona V,
Kowalski ML, Jutel M, Poziomkowska-Gesicka I, Papadopoulos NG, Beyer K, Mustakov
T, Christoff G, Bilò MB, Muraro A, Hourihane JOB, Grabenhenrich LB: First European
data from the network of severe allergic reactions (NORA). Allergy 2014, 69:1397–
404.
21. Ferrer M, Bartra J, Giménez-Arnau A, Jauregui I, Labrador-Horrillo M, de Frutos JO,
Silvestre J, Sastre J, Velasco M, Valero A: Management of urticaria: not too
complicated, not too simple. Clin Exp Allergy 2014.
22. Labirua-Iturburu A, Selva-O’Callaghan A, Martínez-Gómez X, Trallero-Araguás E,
Labrador-Horrillo M, Vilardell-Tarrés M: Calcineurin inhibitors in a cohort of patients
with antisynthetase-associated interstitial lung disease. Clin Exp Rheumatol , 31:436–
9.
23. Labrador-Horrillo M, Martinez MA, Selva-O’Callaghan A, Trallero-Araguas E, Balada E,
Vilardell-Tarres M, Juárez C: Anti-MDA5 antibodies in a large Mediterranean
population of adults with dermatomyositis. J Immunol Res 2014, 2014:290797.
24. Labrador-Horrillo M, Martínez MA, Selva-O’Callaghan A, Trallero-Araguás E, GrauJunyent JM, Vilardell-Tarrés M, Juarez C: Identification of a novel myositis-associated
antibody directed against cortactin. Autoimmun Rev 2014, 13:1008–12
25. Justicia JL, Cardona V, Guardia P, Ojeda P, Olaguibel JM, Vega JM, Vidal C, Baro E,
Garcia MA: Validation of the first treatment-specific questionnaire for the
assessment of patient satisfaction with allergen-specific immunotherapy in allergic
patients: The ESPIA questionnaire. J Allergy Clin Immunol 2013, 131:1539-46.
26. Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M,
Guilá M, de Torres I, Azpiroz F, Santos J, Vicario M: Diarrhoea-predominant irritable
bowel syndrome: an organic disorder with structural abnormalities in the jejunal
epithelial barrier. Gut 2013, 62:1160–8.
27. Blasco AJ, Lázaro P, Caballero T, Guilarte M: Social costs of icatibant selfadministration vs. health professional-administration in the treatment of hereditary
angioedema in Spain. Health Econ Rev 2013, 3:2.
28. Sala-Cunill A, Cardona V, Labrador-Horrillo M, Luengo O, Esteso O, Garriga T, Vicario
M, Guilarte M: Usefulness and limitations of sequential serum tryptase for the
diagnosis of anaphylaxis in 102 patients. International archives of allergy and
immunology 2013, 160(2):192-199
29. Muñoz-García E, Luengo-Sánchez O, Haroun-Díaz E, Maroto AS, Palacín A, Díaz-Perales
A, de las Heras Gozalo M, Labrador-Horrillo M, Vivanco F, Cuesta-Herranz J, PastorVargas C: Identification of thaumatin-like protein and aspartyl protease as new major
allergens in lettuce (Lactuca sativa). Mol Nutr Food Res 2013, 57:2245–52.
30. Papadopoulos NG, Agache I, Bavbek S, Bilo BM, Braido F, Cardona V, Custovic A,
Demonchy J, Demoly P, Eigenmann P et al: Research needs in allergy: an EAACI
position paper, in collaboration with EFA. Clinical and translational allergy 2012,
2(1):21.
31. Calderon MA, Demoly P, Gerth van Wijk R, Bousquet J, Sheikh A, Frew A, Scadding G,
Bachert C, Malling HJ, Valenta R et al: EAACI: A European Declaration on
Immunotherapy. Designing the future of allergen specific immunotherapy. Clinical
and translational allergy 2012, 2(1):20.
32. Cardona V, Luengo O, Garriga T, Labrador-Horrillo M, Sala-Cunill A, Izquierdo A, Soto L,
Guilarte M: Co-factor-enhanced food allergy. Allergy 2012, 67(10):1316-1318.
33. Martínez C, Vicario M, Ramos L, Lobo B, Mosquera JL, Alonso C, Sánchez A, Guilarte M,
Antolín M, de Torres I, González-Castro AM, Pigrau M, Saperas E, Azpiroz F, Santos J:
The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular
alterations in the tight junction signaling pathway that are associated with mucosal
pathobiology and clinical manifestations. Am J Gastroenterol 2012, 107:736–46.
34. Prior N, Remor E, Gomez-Traseira C, Lopez-Serrano C, Cabanas R, Contreras J, Campos
A, Cardona V, Cimbollek S, Gonzalez-Quevedo T et al: Development of a diseasespecific quality of life questionnaire for adult patients with hereditary angioedema
due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project.
Health and quality of life outcomes 2012, 10:82.
35. Barber D, Arias J, Boquete M, Cardona V, Carrillo T, Gala G, Gamboa P, Garcia-Robaina
JC, Hernandez D, Sanz ML et al: Analysis of mite allergic patients in a diverse territory
by improved diagnostic tools. Clinical and experimental allergy : journal of the British
Society for Allergy and Clinical Immunology 2012, 42(7):1129-1138.
36. Calderon M, Cardona V, Demoly P: One hundred years of allergen immunotherapy
European Academy of Allergy and Clinical Immunology celebration: review of
unanswered questions. Allergy 2012, 67(4):462-476.
37. Garriga T, Labrador-Horrillo M, Guillen M, Luengo O, Eseverri JL, Guilarte M, Marin
AM, Cardona V: Spirometric maneuvers and inhaled salbutamol do not affect exhaled
nitric oxide measurements among patients with allergic asthma. Respiration;
international review of thoracic diseases 2012, 83(3):239-244.
38. Trallero-Araguás E, Rodrigo-Pendás JÁ, Selva-O’Callaghan A, Martínez-Gómez X, Bosch
X, Labrador-Horrillo M, Grau-Junyent JM, Vilardell-Tarrés M: Usefulness of anti-p155
autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review
and meta-analysis. Arthritis Rheum 2012, 64:523–32.
39. Labrador-Horrillo M, Martínez MA, Selva-O’Callaghan A, Trallero-Araguás E, Balada E,
Vilardell-Tarrés M, Juarez C: Anti-TIF1γ antibodies (anti-p155) in adult patients with
dermatomyositis: comparison of different diagnostic assays. Ann Rheum Dis 2012,
71:993–6.
40. Vicario M, Alonso C, Guilarte M, Serra J, Martínez C, González-Castro AM, Lobo B,
Antolín M, Andreu AL, García-Arumí E, Casellas M, Saperas E, Malagelada JR, Azpiroz F,
Santos J: Chronic psychosocial stress induces reversible mitochondrial damage and
corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and
IBS-like gut dysfunction. Psychoneuroendocrinology 2012, 37:65–77.
41. Caballero T, Baeza ML, Cabañas R, Campos A, Cimbollek S, Gómez-Traseira C,
González-Quevedo T, Guilarte M, Jurado-Palomo GJ, Larco JI, López-Serrano MC,
López-Trascasa M, Marcos C, Muñoz-Caro JM, Pedrosa M, Prior N, Rubio M, Sala-Cunill
A: Consensus statement on the diagnosis, management, and treatment of
angioedema mediated by bradykinin. Part I. Classification, epidemiology,
pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin
Immunol 2011, 21:333–47; quiz follow 347.
42. Caballero T, Baeza ML, Cabañas R, Campos A, Cimbollek S, Gómez-Traseira C,
González-Quevedo T, Guilarte M, Jurado-Palomo J, Larco JI, López-Serrano MC, LópezTrascasa M, Marcos C, Muñoz-Caro JM, Pedrosa M, Prior N, Rubio M, Sala-Cunill A:
Consensus statement on the diagnosis, management, and treatment of angioedema
mediated by bradykinin. Part II. Treatment, follow-up, and special situations. J
Investig Allergol Clin Immunol 2011, 21:422–41; quiz 442–3.
43. Akdis C, Papadopoulos N, Cardona V: Fighting allergies beyond symptoms: the
European Declaration on Immunotherapy. European journal of immunology 2011,
41(10):2802-2804.
44. Justicia JL, Baro E, Cardona V, Guardia P, Ojeda P, Olaguibel JM, Vega JM, Vidal C:
Development of a questionnaire to assess patient satisfaction with allergen-specific
immunotherapy in adults: item generation, item reduction, and preliminary
validation. Patient preference and adherence 2011, 5:239-250.
45. Sala Cunill A, Labrador-Horrillo M, Guilarte M, Luengo O, Cardona V: Generalised
delayed desquamative exanthema after intradermal testing with betalactam
antibiotics. Allergy 2011, 66(5):702-703.
46. Cardona V, Guilarte M, Luengo O, Labrador-Horrillo M, Sala-Cunill A, Garriga T: Allergic
diseases in the elderly. Clinical and translational allergy 2011, 1(1):11.
47. Cardona Dahl V: [Guideline for the management of anaphylaxis]. Medicina clinica
2011, 136(8):349-355.
PREMIS A COMUNICACIONS
1. Sala A, Guilarte M, Labrador M, Luengo O, Cardona V. “Mastocytosis in the
differential diagnosis of anaphylaxis of Known etiology” GALEN/EAACI Allergy
School in Hannover. 29 de septiembre de 2006.
2. Rueda M, Guilarte M, Luengo O, Sala A, Labrador M, Cardona V. "Impact of
adrenaline auto-injector prescription in anaphylaxis”. XXVII Congress of the
European Academy of Allergology and Clinical Immunology. Barcelona, 10 de
juny de 2008. Allergy 2008; Suppl.
3. A.Izquierdo, A.Sala, T.Garriga, M.Rueda, V.Cardona.¿Existe el síndrome
hemofagocítico recidivante? Matí Al.lergològic de la Societat Catalana
d´Al.lergologia i Immunologia Clínica. Hospital Universitari Sant Joan de Reus,
Tarragona, 24 de gener de 2009.
4. Garriga T, Guilarte M, Luengo O, Labrador M, Sala A, Guillen M, Cardona V
Quality of life in patients with eosinophilic esophagitis. XXVIII Congress of the
European Academy of Allergology and Clinical Immunology. Warszawa. 9 de
junio de 2009. Allergy 2009; Suppl. (Con premio)
5. L.Soto, M. Guilarte, S. Gelis, A. Sala, V. Cardona.Hemodiàlisi: Sol.lució o
problema? . Matí Al.lergològic de la Societat Catalana d´Al.lergologia i
Immunologia Clínica. Hospital Universitari de Girona Doctor Josep Trueta.
Girona, 23 de gener de 2010.
6. T.Garriga, O.Luengo, M. Labrador, M.Guilarte, A.Sala, S.Gelis, O.Esteso,
R.Ocaña, V.Cardona. “Avaluació i impacte de l´aplicació d´al.lèrgens
recombinants en el diagnòstic de pacients polisensibilitzats de Barcelona”.
Jornada de Cloenda de la SCAIC. Barcelona 28 y 29 de mayo de 2010.
7. Sala Cunill A, Guilarte M, Labrador M, Luengo O, Esteso O, Garriga T, Cardona V.
Anaphylaxis: usefulness of tryptase in patients attending an emergency
department. XXIX Congress of the European Academy of Allergology and
Clinical Immunology. London. 8 june 2010. Allergy 2010; Suppl.
8. A.Garía Moral, M Labrador, L. Soto, A.Izquierdo, O.Esteso, T.Garriga, A.Sala,
M.Guilarte, O.Luengo, V. Cardona. “Aprofitar una estrella Michelín”: Matí
Al.lergològic de la Societat Catalana d´Al.lergologia i Immunologia Clínica, Valls
22 de enero de 2011.
9. Garriga S, Lara M, Soto L, Guilarte M, Luengo O, Sala A, Labrador M, Cardona V.
“The woman in blue”. Matí Al.lergològic de la Societat Catalana d´Al.lergologia
i Immunologia Clínica, Sabadell 28 de enero de 2012.
10. Guilarte M, Luengo O, Garriga T, Sala-Cunill A, Labrador M, Soto L, Izquierdo A,
Cardona V. “Al.lèrgia a aliments potenciada per cofactor; una entitat no tan
infreqüent”, Jornada de Cloenda de la Sociedad Catalana de Alergia e
Inmunología clínica. 25 de mayo de 2012. Barcelona.
11. Sala A, Guilarte M, Cardona V, Björkqvist J, Labrador M, Nickel K, Renné T.
“Activació del Sistema de Contacte durant l´anafilaxia“ , Jornada de Cloenda
de la Sociedad Catalana de Alergia e Inmunología Clínica. El 31 de mayo de
2013. Barcelona.
12. Gómez Duque M.1, Blasco Valero C.1, Vilá Indurain B.1, Pineda de la Losa F.2,
Rivière J.G.1, Guillen Biscarri M.1, Soley Galán R.1, Garriga Baraut T.1.
Sensitisation patterns of Alternaria alternata in a pediatric population of our
Mediterranean area. EAACI 2015, 6-11 Juny 2015, Barcelona.
BEQUES i PROJECTES FINANCIATS
1. EAACI Clinical Fellowship Award 2009: Teresa Garriga
2. EAACI Clinical Fellowship Award 2010: Olga Esteso
3. Beca de la SEAIC 2009. “Anafilaxia por Alimentos dependiente de
Cofactores: Desarrollo de un modelo experimental y estudio del papel del
mastocito en la modulación de la permeabilidad intestinal”. Investigadores:
Mar Guilarte, Victòria Cardona, Anna Sala, Olga Esteso, María Vicario.
4. Beca de la SCAIC 2009. “Estudi RECORD (al.lergens RECOmbinants en
Resolució Diagnòstica)”. Investigadores: Victòria Cardona, Mar Guilarte,
Olga Luengo, Moises Labrador, Anna Sala. “Contrato de Formación en
Investigación Río Hortega para profesionales sanitarios” del Instituto Carlos
III de Madrid. Obtenido en Diciembre de 2009. Anna Sala Cunill. Hospital
Universitari Vall d´Hebron.
5. Beca PHADIA “ In memoriam Dr. Jaume Boety” al proyecto: Anafilaxia por
alimentos mediada por cofactores: función reguladora del mastócit y de la
permeabilidad intestinal. De la SCAIC. 29 de mayo de 2010. Investigadora
principal: Mar Guilarte. Investigadors Col.laboradors: Olga Esteso, Anna
Sala Cunill, Moises Labrador, Olga Luengo y Victòria Cardona.
6. Proyecto FIS del Ministerio de Ciencia e Innovación, Instituto de Salud
Carlos III, Fondo de Investigación Sanitaria: PI10/01871 . Investigador
principal: Moises Labrador Horrillo. Investigadores Colaboradores: Anna
Sala Cunill, Mar Guilarte, Olga Esteso, Olga Luengo y Victòria Cardona.
7. Beca SEAIC para formación en el extranjero. Junio de 2012. Anna Sala
Cunill.
8. Beca de la SEAIC 2015. “Estratificación de riesgo en anafilaxia”.
Investigadora principal: Anna Sala Cunill. Investigadores colaboradores:
Mar Guilarte, Victòria Cardona, Olga Luengo, Moisés Labrador.
9. Beca de la SCAIC 2015. “Estudi prospectiu sobre la Implicació del sistema
de contacte en l´anafilaxi i estratificació de risc”. Investigadora principal:
Anna Sala Cunill. Investigadores colaboradores: Mar Guilarte, Victòria
Cardona, Olga Luengo, Moisés Labrador.